Total investments received (USD): N/A
Round value (USD): 110.11m
Company: Neogene Therapeutics
Industry:
Biotech
Health services









Belgium
Austria
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
Ireland
Italy
Portugal
Spain